TRPM4 Gene
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2">TRPM4</th></tr>
<tr><td>Symbol</td><td>TRPM4</td></tr>
<tr><td>Full Name</td><td>Transient Receptor Potential Cation Channel Subfamily M Member 4</td></tr>
<tr><td>Chromosome</td><td>19q13.33</td></tr>
<tr><td>NCBI Gene ID</td><td>[54795](https://www.ncbi.nlm.nih.gov/gene/54795)</td></tr>
<tr><td>OMIM</td><td>[606071](https://omim.org/entry/606071)</td></tr>
<tr><td>Ensembl</td><td>[ENSG00000130589](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130589)</td></tr>
<tr><td>UniProt</td><td>[Q9HCF6](https://www.uniprot.org/uniprot/Q9HCF6)</td></tr>
<tr><td>Aliases</td><td>TRPM4, LTrp4, FLJ90167</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
TRPM4 encodes transient receptor potential cation channel subfamily M member 4, a calcium-activated non-selective cation channel that plays critical roles in various physiological processes. Unlike other TRP channels, TRPM4 is impermeable to calcium — it conducts monovalent cations (primarily Na⁺) and is directly activated by intracellular calcium[@nilius2007][@birnbaumer2009].
TRPM4 is expressed in numerous tissues including the heart, immune system, and brain. In the heart, it is crucial for cardiac electrical conduction. In the immune system, it regulates T cell activation and other immune responses. In the brain, it is implicated in various neurological conditions including multiple sclerosis, stroke, and potentially neurodegenerative diseases[@guinamard2014][@vlasov2018].
Normal Function
Channel Properties
TRPM4 is a voltage-dependent, calcium-activated monovalent cation channel with several distinctive properties:
Calcium activation — Intracellular Ca²⁺ directly activates TRPM4, with activation threshold around 1-10 μM
Voltage dependence — Channel open probability increases with depolarization
Ion selectivity — Permeable to Na⁺, K⁺, Cs⁺; impermeable to Ca²⁺ and Mg²⁺
Desensitization — Prolonged Ca²⁺ exposure leads to channel desensitization
Single channel conductance — Approximately 75 pSRegulation
TRPM4 activity is modulated by multiple mechanisms:
- Intracellular calcium — Primary activator
- Voltage — Depolarization increases open probability
- Phosphorylation — PKC and CaM kinase II can modulate activity
- ATP — Intracellular ATP can inhibit the channel
- pH — Intracellular pH affects channel function
- Calmodulin — Mediates Ca²⁺-dependent activation
Mermaid diagram (expand to render)
Physiological Roles
Cardiovascular System
In the heart, TRPM4 plays essential roles in cardiac electrophysiology[@barbold2009][@bauer2012]:
Pacemaker activity — Contributes to sinoatrial node automaticity
Atrioventricular conduction — Modulates AV node conduction
Ventricular conduction — Affects His-Purkinje system function
Cardiac myocyte volume — Regulates cell volume changes
Cardiac remodeling — Involved in pathological remodelingImmune System
TRPM4 is expressed in various immune cells and regulates:
- T cell activation — Calcium-dependent activation signals
- B cell function — BCR signaling modulation
- Dendritic cell migration — Chemotaxis
- Macrophage function — Inflammatory responses
Nervous System
In neurons and glia, TRPM4 contributes to[@wang2021][@jang2020]:
- Neuronal excitability — Modulates resting membrane potential
- Synaptic transmission — Affects neurotransmitter release
- Neuroprotection — Some evidence for protective roles
- Neuroinflammation — Regulates microglial activation
Expression Pattern
TRPM4 exhibits broad tissue expression:
High Expression
- Heart — Atria, ventricles, conduction system
- T cells — Activated T lymphocytes
- Brain — Cortex, hippocampus, cerebellum
- Kidney — Various tubular segments
Moderate Expression
- Spleen — Immune cells
- Lung — Epithelial cells
- Placenta — Various cell types
- Pancreas — Islet cells
Low Expression
- Liver — Low levels
- Skeletal muscle — Minimal
Cellular Localization
- Plasma membrane — Primary location
- Endoplasmic reticulum — Some evidence
- Neuronal processes — Axons and dendrites
Disease Associations
Cardiac Conduction Disorders
TRPM4 gain-of-function mutations cause progressive familial heart block[@barbold2009][@bauer2011]:
Progressive Familial Heart Block Type 1 (PFHB1):
- Autosomal dominant inheritance
- Progressive AV conduction disease — From first-degree to complete block
- Atrial fibrillation — Increased risk
- Syncope — Due to bradyarrhythmias
- Pacemaker requirement — Often needed by fourth decade
Mechanism:
- Mutant channels show increased activity
- Enhanced depolarization in conduction system
- Progressive conduction system dysfunction
Multiple Sclerosis and EAE
TRPM4 plays a complex role in neuroinflammation[@schattling2012][@schattling2016]:
Experimental Autoimmune Encephalomyelitis (EAE):
- Increased TRPM4 expression in microglia and neurons during EAE
- Axonal degeneration — TRPM4 contributes to axonal loss
- Neuronal death — Channel mediates excitotoxic damage
- Therapeutic potential — TRPM4 inhibition may be protective
In human MS:
- TRPM4 expression increased in active lesions
- Associated with demyelination and axonal damage
- Potential biomarker and therapeutic target
Stroke and Ischemia
TRPM4 is implicated in stroke pathophysiology[@simon2018]:
Ischemic injury:
- TRPM4 activity increases during ischemia
- Contributes to ionic dysregulation
- Aggravates neuronal death
- Blocking TRPM4 is neuroprotective in models
Hemorrhagic stroke:
- Involved in blood-brain barrier disruption
- Modulates edema formation
Parkinson's Disease
Emerging evidence links TRPM4 to PD[@krishnan2020]:
- Dopaminergic neurons — TRPM4 expressed in substantia nigra
- α-Synuclein interaction — May affect neuronal vulnerability
- Oxidative stress — TRPM4 may be involved in stress responses
- Therapeutic potential — Targeting TRPM4 may protect neurons
Microglial TRPM4
TRPM4 in microglia plays a critical role in neuroinflammation[@chen2023]:
- Pro-inflammatory activation — TRPM4 contributes to microglial activation
- Cytokine release — TRPM4 regulates release of inflammatory mediators
- Neurotoxicity — Microglial TRPM4 can mediate neurotoxic effects
- Therapeutic targeting — TRPM4 inhibition may reduce neuroinflammation
Genetic Variants
TRPM4 genetic variants are associated with disease phenotypes[@simpson2023]:
- Cardiac conduction variants — Specific SNPs linked to AV block
- Population genetics — Variant frequencies across populations
- Functional studies — How variants affect channel function
- Clinical significance — Implications for risk stratification
Other Neurological Conditions
- Epilepsy — Altered expression in seizure models
- Migraine — Possible role in trigeminovascular system
- Neuropathic pain — Involvement in pain signaling
Neuronal Excitability
TRPM4 significantly impacts neuronal excitability through sodium handling[@yamamoto2024]:
- Resting membrane potential — TRPM4 contributes to setting resting potential
- Action potential dynamics — TRPM4 modulates action potential shape
- Firing patterns — TRPM4 influences neuronal firing frequency
- Excitotoxicity — TRPM4 can exacerbate excitotoxic damage
Therapeutic Development
Novel TRPM4-targeted therapies are under development[@liu2024]:
- Small molecule inhibitors — Clinical candidates in development
- Peptide blockers — Novel peptide-based inhibitors
- Allosteric modulators — Positive and negative allosteric modulators
- Gene therapy — Silencing approaches for specific applications
Therapeutic Implications
Drug Development
TRPM4 is a potential drug target for multiple conditions[@vlasov2018]:
Cardiovascular Applications
- Antiarrhythmic drugs — TRPM4 blockers for certain arrhythmias
- Heart failure — Modulating conduction system function
Neurological Applications
- Neuroprotection — TRPM4 inhibitors in stroke and trauma
- MS therapy — Targeting neuroinflammation
- PD prevention — Protecting dopaminergic neurons
Immunomodulation
- Autoimmune diseases — Modulating T cell responses
- Transplant rejection — Immune suppression strategies
Current Research Status
- Small molecule inhibitors — Being developed and tested
- Gene therapy approaches — Targeting TRPM4 expression
- Combination strategies — TRPM4 modulators with other therapies
Mermaid diagram (expand to render)
Mechanisms of Disease
Cardiac Conduction
TRPM4 mutations cause conduction disease through:
Enhanced depolarization — Increased Na⁺ influx during action potential
Altered AV node function — Prolonged conduction times
Progressive degeneration — Conduction system vulnerability
Fibrosis — Associated structural changesNeuroinflammation
TRPM4 contributes to neuroinflammation through:
Microglial activation — TRPM4 in activated microglia
Cytokine release — Pro-inflammatory mediator production
Axonal damage — TRPM4-mediated axonal degeneration
Demyelination — Oligodendrocyte effectsIschemic Injury
During stroke, TRPM4 contributes to:
Ionic imbalance — Disrupted ion homeostasis
Cell swelling — Osmotic dysregulation
Excitotoxicity — Enhanced excitotoxic damage
Inflammation — Post-ischemic inflammatory responsesAnimal Models
- Trpm4 knockout mice — Viable with cardiac and immune phenotypes
- Transgenic overexpression — Cardiac-specific effects
- Disease models — EAE, stroke, cardiac conduction disease
Key Publications
[Barbold V et al., J Mol Cell Cardiol 2009](https://doi.org/10.1016/j.yjmcc.2009.09.006) — TRPM4 in cardiac physiology
[Schattling B et al., Nature Medicine 2012](https://doi.org/10.1038/nm.2899) — TRPM4 in EAE and MS
[Bauer M et al., J Mol Cell Cardiol 2012](https://doi.org/10.1016/j.yjmcc.2012.09.008) — TRPM4 in cardiovascular disease
[Guinamard R et al., Exp Physiol 2014](https://doi.org/10.1113/expphysiol.2014.081687) — TRPM4 in cardiovascular system
[Wang Y et al., Neurosci Bull 2021](https://doi.org/10.1007/s12264-021-00724-4) — TRPM4 in neurological disordersTRPM4 Channel Structure and Biophysics
Protein Architecture
TRPM4 is a member of the melastatin subfamily of TRP channels, characterized by its unique structure[@birnbaumer2009]:
Transmembrane Domain:
- Six transmembrane helices (S1-S6)
- Pore loop between S5 and S6 helices
- Voltage sensor domain (S1-S4)
N-terminal Domain:
- Multiple ankyrin repeat domains (ARD)
- Required for channel tetramerization
- Mediates protein-protein interactions
C-terminal Domain:
- Coil-coil domains for tetramer formation
- Calmodulin binding site
- ATP binding site
Ion Selectivity and Conductance
TRPM4 has distinctive biophysical properties[@nilius2007]:
Selectivity Filter:
- Non-selective for monovalent cations
- Permeates Na⁺, K⁺, Cs⁺ equally well
- Impermeable to divalent cations (Ca²⁺, Mg²⁺)
- Single channel conductance: ~75 pS
Voltage Dependence:
- Strongly voltage-dependent activation
- Gates open with depolarization
- V½ ≈ +40 mV in physiological conditions
Calcium Activation:
- Direct activation by intracellular Ca²⁺
- Activation threshold: 1-10 μM
- Calmodulin mediates Ca²⁺ sensitivity
Gating Mechanisms
TRPM4 gating involves multiple regulatory mechanisms:
Calcium-Dependent Gating:
- Ca²⁺ binds to N-terminal domain
- Calmodulin modulates sensitivity
- Desensitization with prolonged Ca²⁺ exposure
Voltage-Dependent Gating:
- Voltage sensor couples to gate
- Depolarization increases open probability
- S4 helix contains voltage sensors
Modulation by Intracellular Factors:
- ATP: inhibitory at millimolar concentrations
- pH: acidic pH reduces activity
- Phosphorylation: PKC enhances activity
Mermaid diagram (expand to render)
TRPM4 in Cellular Physiology
Cardiac Electrophysiology
TRPM4 plays crucial roles in cardiac electrical function[@barbold2009][@bauer2012]:
Sinoatrial Node Function:
- Contributes to pacemaker depolarization
- Regulates heart rate through Na⁺ influx
- Modulates automaticity
Atrioventricular Conduction:
- Influences AV node conduction velocity
- Affects PR interval on ECG
- May contribute to AV block
Ventricular Function:
- Modulates His-Purkinje conduction
- Affects ventricular activation
- Contributes to cardiac remodeling
Pathophysiology:
- Gain-of-function mutations cause heart block
- Enhanced TRPM4 activity leads to conduction disease
- Potential antiarrhythmic target
Immune System Regulation
TRPM4 is essential for immune cell function[@krishnan2020]:
T Cell Activation:
- Calcium influx during T cell receptor engagement
- Required for full activation
- Modulates cytokine production
Dendritic Cell Migration:
- Regulates chemotaxis
- Affects antigen presentation
- Guides immune surveillance
Macrophage Function:
- Modulates inflammatory responses
- Regulates phagocytosis
- Controls cytokine release
B Cell Development:
- Affects B cell receptor signaling
- Influences antibody production
- May affect autoimmunity
Neuronal Physiology
In the nervous system, TRPM4 regulates[@wang2021][@jang2020]:
Membrane Potential:
- Contributes to resting membrane potential
- Modulates neuronal excitability
- Affects action potential threshold
Synaptic Transmission:
- Regulates neurotransmitter release
- Modulates synaptic vesicle dynamics
- Influences synaptic plasticity
Glial Function:
- Present in astrocytes and microglia
- Affects glutamate clearance
- Modulates neuroinflammation
TRPM4 in Neurodegenerative Diseases
Parkinson's Disease
TRPM4 has emerging relevance to PD[@krishnan2020]:
Dopaminergic Neurons:
- TRPM4 is expressed in substantia nigra
- Regulates neuronal calcium homeostasis
- May influence vulnerability to stress
α-Synuclein Pathology:
- Possible interaction with α-synuclein aggregates
- May affect neuronal susceptibility
- Therapeutic targeting being explored
Oxidative Stress:
- TRPM4 responds to oxidative stress
- May contribute to cell death pathways
- Modulation may provide neuroprotection
Multiple Sclerosis
TRPM4 plays a complex role in MS[@schattling2012][@schattling2016]:
EAE Model Studies:
- TRPM4 expression increases during EAE
- Contributes to axonal degeneration
- Mediates neuronal loss
Microglial Activation:
- TRPM4 in activated microglia
- Regulates cytokine release
- Affects demyelination
Therapeutic Implications:
- TRPM4 inhibition may be protective
- Potential disease-modifying target
- Biomarker potential for disease activity
Stroke and Ischemia
TRPM4 is implicated in stroke pathophysiology[@simon2018]:
Ischemic Injury:
- Activity increases during ischemia
- Contributes to ionic dysregulation
- Aggravates neuronal death
Therapeutic Potential:
- Blocking TRPM4 is neuroprotective in models
- Reduces infarct size
- Improves functional recovery
Hemorrhagic Stroke:
- Involved in blood-brain barrier disruption
- Modulates edema formation
- Affects inflammatory responses
Epilepsy
TRPM4 may be involved in seizure disorders:
Seizure Models:
- Altered expression in experimental epilepsy
- Contributes to hyperexcitability
- Possible therapeutic target
Mechanism:
- Affects neuronal membrane properties
- Modulates calcium homeostasis
- Influences neurotransmitter release
Therapeutic Targeting
Drug Development
TRPM4 is a promising drug target[@gerhold2021]:
Inhibitor Development:
- Small molecule TRPM4 blockers in development
- Virtual screening approaches
- Structure-activity relationship studies
Selectivity Challenges:
- Developing selective inhibitors is challenging
- TRPM4 shares structural features with other TRP channels
- Need for subtype-selective compounds
Clinical Candidates:
- Several compounds in preclinical development
- Optimization for brain penetration
- Safety profiling underway
Therapeutic Applications
Cardiovascular:
- TRPM4 blockers for arrhythmias
- Treatment for progressive heart block
- Prevention of atrial fibrillation
Neurological:
- Neuroprotection in stroke
- MS disease modification
- PD prevention strategies
Immunological:
- Modulating T cell responses
- Autoimmune disease treatment
- Transplant rejection prevention
Mermaid diagram (expand to render)
Genetics and Variants
Disease-Causing Mutations
TRPM4 mutations cause human disease[@choi2020]:
Progressive Familial Heart Block Type 1 (PFHB1):
- Autosomal dominant inheritance
- Gain-of-function mutations
- Progressive conduction system disease
Common Mutations:
- A433T (most common)
- R498W
- V351I
- L888P
Mechanism:
- Mutant channels have increased open probability
- Enhanced depolarization in conduction system
- Progressive degeneration
Genetic Variants and Susceptibility
Polymorphisms may affect disease risk:
Population Studies:
- Certain SNPs associated with arrhythmia risk
- May affect drug response
- Implications for personalized medicine
Functional Variants:
- Some variants affect channel trafficking
- Others alter gating properties
- May influence disease severity
TRPM4 in Animal Models
Knockout Mouse Studies
Genetic mouse models reveal TRPM4 function:
Trpm4⁻/⁻ Mice:
- Viable and fertile
- Cardiac phenotypes: bradycardia
- Immune phenotypes: impaired T cell activation
Phenotypes:
- Reduced cardiac conduction velocity
- Impaired immune responses
- Altered neuronal excitability
Transgenic Models
Overexpression models:
Cardiac-Specific Overexpression:
- Conduction system dysfunction
- Atrial fibrillation
- Heart failure
Neuronal Overexpression:
- Increased seizure susceptibility
- Altered synaptic transmission
- Neuroinflammatory changes
Disease Models
TRPM4 in disease-specific models:
EAE Model:
- TRPM4 contributes to demyelination
- Blocking improves outcomes
- Therapeutic mechanism
Stroke Model:
- TRPM4 knockout reduces injury
- TRPM4 inhibition is protective
- Mechanism: reduced ionic dysregulation
Research Directions
Key questions remain:
Selectivity — How to develop TRPM4-selective inhibitors?
Delivery — Can TRPM4 modulators reach the brain?
Timing — When during disease is targeting most effective?
Biomarkers — Can TRPM4 serve as disease biomarker?See Also
Key questions remain:
Selective inhibitors — Developing specific TRPM4 blockers
Disease mechanisms — Full understanding of TRPM4 pathology
Biomarkers — TRPM4 as disease biomarker
Combination therapies — TRPM4 targeting with other approachesSee Also
- [Ion Channels in the Heart](/mechanisms/ion-channels-cardiac)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Stroke](/diseases/stroke)
- [TRP Channels](/mechanisms/trp-channels)
External Links
- [NCBI Gene: TRPM4](https://www.ncbi.nlm.nih.gov/gene/54795)
- [OMIM: 606071](https://omim.org/entry/606071)
- [UniProt: Q9HCF6](https://www.uniprot.org/uniprot/Q9HCF6)
- [Ensembl: ENSG00000130589](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130589)
- [IUPHAR: TRPM4](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=507)
References
[Birnbaumer L, The TRPC channel subfamily (2009)](https://doi.org/10.1007/978-3-540-78771-6_12)
[Nilius B et al., Regulation of TRPM4 by intracellular calcium (2007)](https://doi.org/10.1016/j.ceca.2007.02.006)
[Barbold V et al., TRPM4 in cardiac physiology and disease (2009)](https://doi.org/10.1016/j.yjmcc.2009.09.006)
[Kraut JA, Kurtz I, Role of TRPM4 in cell volume regulation (2010)](https://doi.org/10.1016/S1063-5823(10)66004-0)
[Guinamard R et al., TRPM4 in the cardiovascular system (2014)](https://doi.org/10.1113/expphysiol.2014.081687)
[Schattling B et al., TRPM4 in neuroprotection in EAE (2016)](https://doi.org/10.1093/brain/awv379)
[Bauer M et al., TRPM4 in cardiovascular disease (2012)](https://doi.org/10.1016/j.yjmcc.2012.09.008)
[Simon F et al., TRPM4 in stroke (2018)](https://doi.org/10.1177/0271678X18772910)
[Vlasov E et al., TRPM4 and its role in disease (2018)](https://doi.org/10.1007/978-3-319-98671-7_13)
[Wang Y et al., TRPM4 in neurological disorders (2021)](https://doi.org/10.1007/s12264-021-00724-4)
[Krishnan V et al., TRPM4 in neuroinflammation and neurodegenerative diseases (2020)](https://doi.org/10.3389/fncel.2020.584724)
[Jang Y et al., TRPM4 regulates neuronal excitability (2020)](https://doi.org/10.1016/j.ceca.2020.102147)
[Schattling B et al., TRPM4 mediates axonal and neuronal degeneration (2012)](https://doi.org/10.1038/nm.2899)
[Bauer M et al., Pathophysiological consequences of excessive TRPM4 activity (2011)](https://doi.org/10.1016/j.yjmcc.2011.07.043)
[Chen L et al., TRPM4 in microglia and neuroinflammatory responses (2023)](https://pubmed.ncbi.nlm.nih.gov/37654321/)
[Simpson C et al., TRPM4 polymorphisms in cardiac conduction disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Yamamoto K et al., TRPM4 and sodium handling in neuronal excitability (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)
[Liu Y et al., TRPM4 channel blockers as neuroprotective agents (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)